Quantum BioPharma Ltd. (QNTM)

Quantum BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.12	2.76	16.98	35.26	17.52	5.97
Short-Term Investments	3.49	0.76	-	0.16	-	-
Cash & Short-Term Investments	6.61	3.51	16.98	35.42	17.52	5.97
Cash Growth	51.04%	-79.31%	-52.06%	102.10%	193.66%	-71.76%
Accounts Receivable	6.98	7.19	0.02	-	-	-
Other Receivables	0.1	0.23	0.37	0.5	0.16	1.56
Receivables	7.09	7.42	0.4	0.5	0.16	1.56
Inventory	-	-	-	-	-	0.71
Prepaid Expenses	0.1	0.12	0.16	0.76	0.57	0.32
Other Current Assets	0.05	0.03	0.31	9.25	8.61	-
Total Current Assets	13.84	11.09	17.85	45.93	26.87	8.56
Property, Plant & Equipment	0.14	0.12	0.26	0.17	-	8.98
Long-Term Investments	0.01	0.01	0.83	0.66	1.68	8.86
Other Intangible Assets	5.04	5.36	12.04	16.2	13.42	16.82
Long-Term Accounts Receivable	-	0.91	7.43	-	-	-
Total Assets	19.03	17.47	38.41	62.96	41.97	43.22
Accounts Payable	1.35	3.24	2.76	3	2.06	3.29
Accrued Expenses	1.96	0.95	4.35	4.46	1.62	0.07
Short-Term Debt	0.3	0.3	0.3	0.3	0.38	1.44
Current Portion of Leases	0.07	0.04	0.18	0.12	0.05	0.04
Other Current Liabilities	0	0.03	0.24	0.83	1.46	1.99
Total Current Liabilities	3.68	4.57	7.83	8.7	5.58	6.83
Long-Term Leases	-	-	0.04	0.13	0.08	0.11
Total Liabilities	3.68	4.57	7.87	8.83	5.66	6.94
Common Stock	149.08	137.78	143.41	152.32	103.21	73.74
Additional Paid-In Capital	31.13	30.23	28.5	22.58	18.79	17.37
Retained Earnings	-166.75	-157.91	-144.16	-126.15	-90.87	-59.07
Comprehensive Income & Other	2.83	3.14	2.8	5.38	5.18	4.24
Total Common Equity	16.29	13.24	30.54	54.13	36.31	36.28
Minority Interest	-0.94	-0.33	-	-	-	-
Shareholders' Equity	15.35	12.91	30.54	54.13	36.31	36.28
Total Liabilities & Equity	19.03	17.47	38.41	62.96	41.97	43.22
Total Debt	0.37	0.34	0.52	0.56	0.51	1.59
Net Cash (Debt)	6.23	3.17	16.46	34.86	17.01	4.38
Net Cash Growth	55.40%	-80.72%	-52.77%	104.90%	288.50%	-79.28%
Net Cash Per Share	7.86	5.21	27.63	64.84	91.82	40.34
Filing Date Shares Outstanding	1.92	0.62	0.63	0.59	0.54	0.13
Total Common Shares Outstanding	1.86	0.61	0.59	0.62	0.29	0.12
Working Capital	10.16	6.52	10.02	37.23	21.29	1.73
Book Value Per Share	8.74	21.85	51.56	86.98	123.17	298.27
Tangible Book Value	11.25	7.88	18.5	37.93	22.88	19.46
Tangible Book Value Per Share	6.03	13.01	31.23	60.95	77.63	159.97

Source: S&P Capital IQ. Standard template. Financial Sources.